VOLTAS adds in-house ETO sterilization and cuts validation time in half

VOLTAS says its new in-house ethylene oxide sterilization offering gives medical device makers a validated path without outsourcing, reducing sterilization validation time by 50% at the same cost. The service is now available from the company’s ISO 13485-compliant facility in Cottage Grove, Minnesota.

Why it matters: - VOLTAS is trying to remove one of the slowest handoffs in medical device manufacturing: outsourced sterilization. - The company says in-house ETO sterilization can shorten validation timelines by 50% without raising cost for customers. - The setup is aimed at single-use devices that cannot withstand heat or radiation sterilization.

What happened: - VOLTAS launched in-house ethylene oxide sterilization services for medical device companies. - The service is available now from VOLTAS’ ISO 13485-compliant facility in Cottage Grove, Minnesota. - The company says the service covers both development-stage builds and ongoing commercial volumes.

The details: - VOLTAS handles validation and cycle development on-site, rather than sending product to an outside vendor. - The company says its in-house process reduces scheduling delays tied to external labs. - VOLTAS says devices can move from cleanroom assembly through a validated ETO cycle without leaving the building. - The company says the setup preserves traceability from assembly through sterilization. - Services include in-house ETO sterilization, sterile barrier packaging and labeling, full sterilization validation, cycle development, cleanroom assembly under one roof, and regulatory documentation support. - VOLTAS says it supports sterilization runs from small routine batches to full pallet sterilization. - The company also says it supports terminal sterilization for single-use devices, hardest-to-sterilize studies, and ongoing commercial production. - VOLTAS says device makers work with one project team across sterilization, cleanroom assembly, packaging, and regulatory work. - The company says the service is available to startups and established device manufacturers.

Between the lines: - In-house sterilization can simplify documentation and reduce the coordination burden that comes with managing multiple vendors. - The pitch also suggests VOLTAS wants sterilization to function as part of a broader integrated manufacturing offering, not as a standalone service. - That model may appeal to companies that need faster iteration during development and tighter control during commercial scale-up.

What's next: - VOLTAS says the ETO service is available now. - The company is positioning the offering for both new product development and commercial production workflows. - More information is available here and on VOLTAS’ LinkedIn page. - Jason Scherer is listed as the company contact at +1 303-775-2211.

The bottom line: - VOLTAS is betting that bringing ETO sterilization in-house will save time, simplify validation, and keep more of the device manufacturing process under one roof.